These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15875187)

  • 81. The schedule-dependent effects of etoposide in leukaemic cell lines: a function of concentration and duration.
    Liu WM; Joel SP
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):291-6. PubMed ID: 12721756
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Inhibitory effect of photodynamic therapy combined with paclitaxel on the proliferation of esophageal carcinoma Eca-109 cells].
    Zhang ZF; Huang Y; Shi X; Wang RX; Lin XY; Lin XD; Zheng H; Li LB
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1310-2, 1315. PubMed ID: 20584640
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines.
    Ricotti L; Tesei A; De Paola F; Ulivi P; Frassineti GL; Milandri C; Amadori D; Zoli W
    Clin Cancer Res; 2003 Feb; 9(2):900-5. PubMed ID: 12576465
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro.
    Chou TC; Otter GM; Sirotnak FM
    Cancer Chemother Pharmacol; 1996; 37(3):222-8. PubMed ID: 8529281
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Determination of optimal dosage for nedaplatin based on pharmacokinetic and toxicodynamic analysis.
    Ishibashi T; Yano Y; Oguma T
    Anticancer Res; 2005; 25(2B):1273-81. PubMed ID: 15865078
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Study on the effects of taxol on Hep-2 cell lines in larynx carcinoma].
    Ni G; Dong Y; Wang J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 13(6):265-7. PubMed ID: 12563982
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Different regulatory pathways are involved in the proliferative inhibition of two types of leukemia cell lines induced by paclitaxel.
    Xia RL; Lu Y; Zhu LN; Zhang SF; Zhao FK; Fu CY
    Oncol Rep; 2013 Oct; 30(4):1853-9. PubMed ID: 23877234
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Schedule-dependent interactions between paclitaxel and etoposide in human carcinoma cell lines in vitro.
    Kano Y; Akutsu M; Suzuki K; Mori K; Yazawa Y; Tsunoda S
    Cancer Chemother Pharmacol; 1999; 44(5):381-8. PubMed ID: 10501911
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Modelling cell population growth with applications to cancer therapy in human tumour cell lines.
    Basse B; Baguley BC; Marshall ES; Wake GC; Wall DJ
    Prog Biophys Mol Biol; 2004; 85(2-3):353-68. PubMed ID: 15142752
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Potentiation of antiproliferative drug activity by lonidamine in hepatocellular carcinoma cells.
    Ricotti L; Tesei A; De Paola F; Milandri C; Amadori D; Frassineti GL; Ulivi P; Zoli W
    J Chemother; 2003 Oct; 15(5):480-7. PubMed ID: 14598941
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Effects of paclitaxel loaded ultrasound contrast agents on cell cycles and ultrastructural features of HepG2 cells].
    Liu Y; Kang J; Wu XL; Wang ZG; Wang ZX; Li P
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):360-2. PubMed ID: 18510849
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Schedule-dependent interaction of alpha-difluoromethylornithine and cis-diamminedichloroplatinum(II) against human and hamster pancreatic cancer cell lines.
    Chang BK; Gutman R; Chou TC
    Cancer Res; 1987 May; 47(9):2247-50. PubMed ID: 3105873
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters.
    Kawanishi K; Miyagi Y; Yamamoto J; Miyagi Y; Nakamura K; Kodama J; Hongo A; Yoshinouchi M; Kudo T
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):303-8. PubMed ID: 11345646
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Synergistic apoptotic effects of silibinin in enhancing paclitaxel toxicity in human gastric cancer cell lines.
    Zhang Y; Ge Y; Ping X; Yu M; Lou D; Shi W
    Mol Med Rep; 2018 Aug; 18(2):1835-1841. PubMed ID: 29901126
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Simultaneous estimation of T(G2+M), T(S), and T(pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry.
    White RA; Meistrich ML; Pollack A; Terry NH
    Cytometry; 2000 Sep; 41(1):1-8. PubMed ID: 10942890
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Investigation of the synergistic effects of paclitaxel and herbal substances and endemic plant extracts on cell cycle and apoptosis signal pathways in prostate cancer cell lines.
    Doğan Şiğva ZÖ; Balci Okcanoğlu T; Biray Avci Ç; Yilmaz Süslüer S; Kayabaşi Ç; Turna B; Dodurga Y; Nazli O; Gündüz C
    Gene; 2019 Mar; 687():261-271. PubMed ID: 30453074
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Synergistic effect of paclitaxel and 4-hydroxytamoxifen on estrogen receptor-negative colon cancer and lung cancer cell lines.
    Gu WZ; Chen Z; Tahir SK; Rosenberg SH; Ng SC
    Anticancer Drugs; 1999 Nov; 10(10):895-901. PubMed ID: 10630357
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell lines.
    Taron M; Plasencia C; Abad A; Martin C; Guillot M
    Invest New Drugs; 2000 May; 18(2):139-47. PubMed ID: 10857993
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Jesridonin in combination with paclitaxel demonstrates synergistic anti-tumor activity in human esophageal carcinoma cells.
    Wang C; Yang D; Jiang L; Wang S; Wang J; Zhou K; Shi X; Chang L; Liu Y; Ke Y; Liu H
    Bioorg Med Chem Lett; 2017 May; 27(9):2058-2062. PubMed ID: 28285918
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Molecular mechanisms of paclitaxel and NM-3 on human gastric cancer in a severe combined immune deficiency mice orthotopic implantation model.
    Zhu JS; Song MQ; Chen GQ; Li Q; Sun Q; Zhang Q
    World J Gastroenterol; 2007 Aug; 13(30):4131-5. PubMed ID: 17696236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.